Press release
Rising Prevalence Of Lifestyle Diseases Is Driving Growth Of The PEGylated Proteins Market : A Significant Driver Propelling The PEGylated Proteins Market In 2025
PEGylated Proteins Market
What Is the PEGylated Proteins Market Size and Projected Growth Rate?
The pegylated proteins market, valued at $1.47 billion in 2024, is expected to grow to $1.68 billion in 2025, with a CAGR of 14.1%. This market's growth is attributed to improved therapeutic efficacy, the aging population, a demand for long-acting formulations, enhanced drug safety profiles, and the expanding use of targeted drug delivery systems.
The pegylated proteins market is expected to grow to $2.8 billion by 2029, at a CAGR of 13.7%. The growth is attributed to increased investment in rare diseases, the growth of the biopharmaceutical industry, precision medicine, competition from biosimilars, and innovative market access strategies. Trends include digital health technology integration, next-generation pegylation technologies, personalized formulations, combination therapies, and a shift toward patient-centric healthcare models.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16145
What Are the Major Segments in the PEGylated Proteins Market?
The pegylated proteins market covered in this report is segmented -
1) By Product: Consumable And Services, PEGylation Kits And Reagents, Monofunctional Linear PEGs, Bifunctional PEGs, Services, Other Products
2) By Protein Type: Colony Stimulating Factors, Interferons, Erythropoietin, Recombinant Factor VII, Other Protein Types
3) By Application: Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, Other Applications
4) By End User: Pharmaceuticals, Biotechnology Companies, Contract Research Organizations, Academic Research Institutes
Subsegments:
1) By Consumable And Services: Consumables, Services (Contract Services, PEGylation Services)
2) By PEGylation Kits And Reagents: PEGylation Kits, Reagents
3) By Monofunctional Linear PEGs: Monofunctional PEGs For Protein Modification
4) By Bifunctional PEGs: Bifunctional PEGs For Protein Modification
5) By Other Products: Conjugates, PEGylated Drugs And Therapeutics
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16145&type=smp
What Are The Driving PEGylated Proteins Market Evolution?
The increasing prevalence of lifestyle diseases is expected to fuel the growth of the PEGylated proteins market. Lifestyle diseases, such as obesity, diabetes, and cardiovascular conditions, are becoming more common due to unhealthy habits. PEGylated proteins are used to improve the efficacy and targeted delivery of treatments for these diseases. For example, the Office for Health Improvement and Disparities reported that 64% of adults in England were classified as overweight or obese in 2022-2023, an increase from the previous year. This rise in lifestyle diseases is driving the PEGylated proteins market.
Which Firms Dominate The PEGylated Proteins Market Segments?
Major companies operating in the PEGylated proteins market are Merck & Co. Inc., Bayer AG, Bristol Myers Squibb Company, AstraZeneca PLC, Roche Holding AG, Gilead Sciences Inc., Novo Nordisk A/S, Evonik Industries AG, Viatris Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Lonza Group Ltd., Jazz Pharmaceuticals plc, Ipsen Pharma, Kyowa Kirin Co. Ltd., WuXi Biologics, BioMarin Pharmaceutical Inc., Ligand Pharmaceuticals Incorporated, Zydus Cadila, Enzon Pharmaceuticals Inc.
What Are the Major Trends Shaping the PEGylated Proteins Market?
Major players in the PEGylated protein market are creating advanced PEGylation reagents to strengthen their market position. These compounds attach polyethylene glycol to biomolecules to enhance drug performance. In May 2023, Creative Enzymes, a U.S.-based supplier of enzymes and additives, introduced DSPE-PEG-Maleimide. This PEGylation reagent combines DSPE phospholipids and maleimide groups, enabling the formation of PEGylated liposomes or micelles and supporting targeted drug delivery through thiol-reactive chemistry.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/pegylated-proteins-global-market-report
Which Is The Largest Region In The PEGylated Proteins Market?
North America was the largest region in the PEGylated Proteins market in 2024. The regions covered in the PEGylated proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the PEGylated Proteins Market?
2. What is the CAGR expected in the PEGylated Proteins Market?
3. What Are the Key Innovations Transforming the PEGylated Proteins Industry?
4. Which Region Is Leading the PEGylated Proteins Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Lifestyle Diseases Is Driving Growth Of The PEGylated Proteins Market : A Significant Driver Propelling The PEGylated Proteins Market In 2025 here
News-ID: 4041442 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for PEGylated
PEGylated Proteins Market Size: Strong Growth Ahead (2025-2032)
Latest Market Overview
The global PEGylated proteins market is witnessing significant growth, driven by an expanding range of therapeutic applications and increasing demand for protein-based drugs. In 2024, the PEGylated proteins market is estimated to be valued at USD 7.5 billion, with forecasts projecting a robust growth trajectory through 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 8.2% during the forecast period. The rising…
PEGylated Proteins Market to Witness Robust Expansion by 2024
Market Research Report Store offers a latest published report on PEGylated Proteins Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the PEGylated Proteins market will register a 3.9% CAGR in terms of revenue, the global market size will reach US$ 3819.7 million by 2024, from US$ 3275 million in 2019. In…
PEGylated Proteins Market - Competitive Landscape and Key Product Segments
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in…
PEGylated Proteins Market: Competitive Dynamics & Global Outlook 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global PEGylated Proteins market.
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.
Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/2882/global-pegylated-proteins-market
Global PEGylated Proteins Market: Forecast by…
PEGylated Proteins 2024 Market Research Report
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in…
PEGylated Proteins Market Research Report 2016-2024
The PEGylated Proteins Market report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size.
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation.PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic…
